Skip to main content

Advertisement

Log in

Upregulation of HIV-1 replication in chronically infected cells by ingenol derivatives

  • Brief Report
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

We have previously reported that ingenol derivatives are highly potent inhibitors of human immunodeficiency virus type 1 (HIV-1) replication in acutely infected cells. In this study, however, we have found that some ingenol derivatives strongly enhance the replication of HIV-1 in chronically infected cells at nanomolar concentrations. One of the derivatives could activate nuclear factor κB(NF-κB), a potent inducer of HIV-1 replication, through the activation of protein kinase C (PKC). Whereas another derivative, which affected neither PKC nor NF-κB, significantly enhanced HIV-1 replication, suggesting that a PKC-independent mechanism may also exist in ingenol derivative-induced HIV-1 upregulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received February 23, 1998 Accepted May 21, 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujiwara, M., Okamoto, M., Ijichi, K. et al. Upregulation of HIV-1 replication in chronically infected cells by ingenol derivatives. Arch. Virol. 143, 2003–2010 (1998). https://doi.org/10.1007/s007050050436

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007050050436

Navigation